2023 Annual Meeting | C209 - Headache in Special Populations

Date Thursday 04/27/23

Time 03:30 PM - 05:30 PM EST Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Larry Charleston IV, MD, MSc, FAHS

Topic(s) Headache

Learning Objectives Participants should understand the definition of special populations in headache medicine; key epidemiology of special populations in headache medicine; and be able to define intersectionality and articulate its importance in the care of special populations.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Interpersonal and Communication Skills, Professionalism, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice, Quality Improvement

Program Level Intermediate

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student

Teaching Styles Case-based, Didactic, Audience Participation, Other

Event Timeline
03:30 PM - 03:45 PM EST	Speaker	Introduction to Special Populations in Headache Medicine Larry Charleston IV, MD, MSc, FAHS
03:45 PM - 04:25 PM EST	Speaker	Case Review of Headache Management in Selected Special Populations Larry Charleston IV, MD, MSc, FAHS, Michael Stitzer, MD, Angeliki Vgontzas, MD, Juliana VanderPluym, MD
03:45 PM - 04:25 PM EST	Speaker	Case Review of Headache Management in Selected Special Populations Michael Stitzer, MD
04:25 PM - 04:35 PM EST	Discussion	Questions and Answers Larry Charleston IV, MD, MSc, FAHS
04:35 PM - 04:40 PM EST	Speaker	Introduction to Intersectionality in Health Larry Charleston IV, MD, MSc, FAHS
04:40 PM - 05:20 PM EST	Speaker	Intersectionality in Headache Medicine: A Case-based Panel and Audience-participatory Roundtable Discussion Larry Charleston IV, MD, MSc, FAHS, Michael Stitzer, MD, Angeliki Vgontzas, MD, Juliana VanderPluym, MD
05:20 PM - 05:30 PM EST	Discussion	Questions, Answers, and Closing Remarks Larry Charleston IV, MD, MSc, FAHS

Faculty Disclosures
Larry Charleston IV, MD, MSc, FAHS	Dr. Charleston has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan/AbbVie. Dr. Charleston has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biohaven Biopharmaceuticals. Dr. Charleston has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva Pharmaceuticals. Dr. Charleston has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal Pharmaceuticals. Dr. Charleston has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma Pharmaceuticals. Dr. Charleston has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LinPharma. Dr. Charleston has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Haleon. Dr. Charleston has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Charleston has a non-compensated relationship as a Associate Editor with Headache Journal: The Journal of Head and Face Pain that is relevant to AAN interests or activities. Dr. Charleston has a non-compensated relationship as a Board Member at Large with Alliance for Headache Disorders Advocacy that is relevant to AAN interests or activities. Dr. Charleston has a non-compensated relationship as a Board Member with Clinical Neurological Society of America that is relevant to AAN interests or activities.
Michael Stitzer, MD	Dr. Stitzer has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neurology.
Angeliki Vgontzas, MD	Dr. Vgontzas has nothing to disclose.
Juliana VanderPluym, MD	Dr. VanderPluym has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Neurology and Neuroscience Reports. The institution of Dr. VanderPluym has received research support from Amgen.